texas holdem poker tournament biloxi mississippi
The suit claims that Lilly knew its drug, Zyprexa®, increased the risk to patients of contracting diabetes, yet failed to warn of the danger. The complaint states that in April, 2002, nearly a year and a half before it first warned of the risk of diabetes in the United States, Lilly changed Zyprexa®’s labeling in the United Kingdom and Japan to include warnings regarding the association between the use of Zyprexa® and diabetes-related injuries.“The rapid growth of Zyprexa® sales in the State of Mississippi is primarily due to increased prescriptions by primary care physicians for non-medically accepted indications that are excluded from payment under the provisions of the Mississippi Medicaid Prescription Drug Program. The doctors are prescribing the drug for non-approved uses as a direct response to Lilly’s conduct in marketing the drug.“As a result, Mississippi is spending millions of dollars on Zyprexa® for patients who are not indicated for the drug; and further, who are being harmed by it.“Our investigation presently indicates that about 10% of those patients who have been prescribed Zyprexa® have subsequently developed insulin-dependent diabetes. poker machine free downloadgames free no deposit casino coupons forum gambling sports game online play poker
